HMGCR and homozygous familial hypercholesterolemia: Here, we explore novel molecular strategies to enhance transgene expression through RNAi-mediated knockdown of Hmgcr, the rate-limiting enzyme in cholesterol biosynthesis.9 In this study, we refine and combine both strands of gene therapy into a single therapeutic vector and show its efficacy in a mouse model of hoFH.